-
Does Improved Hospital Management Enhance Healthcare Efficiency? Evidence From County-Level Hospitals in China
Sep 18, 2025, 18:38 PM -
Evaluating the Disease Spectrum and Cost of Care Among Neurology Inpatients in Northeast India: Insights From a Real World, Hospital Based Study
Sep 18, 2025, 18:38 PM -
Healthcare Resource Use of Pediatric and Adult Patients With Seizures Associated With Dravet Syndrome, Lennox-Gastaut Syndrome, or Tuberous Sclerosis Complex in Japan
Sep 18, 2025, 18:38 PM -
Forecasting Survival in Nasopharyngeal Cancer Patients With Diabetes Through Machine Learning: A Population-Based Analysis
Sep 18, 2025, 18:38 PM -
Health Savings Impact of Multivitamin Supplementation in Taiwan: A Dementia Risk Reduction Economic Model
Sep 18, 2025, 18:38 PM -
Adopting a Closed Integrated Peripheral Intravenous Cannula System in an Australian Hospital: Clinical and Economic Impact
Sep 18, 2025, 18:38 PM -
Disparities in Health Outcomes and Care Among ALK-Positive Non-Small Cell Lung Cancer Patients: Real-World Evidence of Social Determinants of Health
Sep 18, 2025, 18:38 PM -
Unpacking the Modular Payment of the Lead Maternity Carer Service in New Zealand: Developing Initial Program Theory in Realist Economic Evaluation
Sep 18, 2025, 18:38 PM -
Predicting Survival in Multiple Myeloma Patients With Diabetes Using Machine Learning: A 20-Year Cohort Study
Sep 18, 2025, 18:38 PM -
Statin Use and the Progression of Parkinson’s Disease: A Population-Based Cohort Study
Sep 18, 2025, 18:38 PM -
Global Landscape of Novel Clinical Trial Designs: A Cross-Sectional Analysis of WHO Registered Trials
Sep 18, 2025, 18:38 PM -
Analysis of Chronic Obstructive Pulmonary Disease Medications Based on Real-World Data
Sep 18, 2025, 18:38 PM -
Treatment Patterns for Chemotherapy-Induced Anemia in Chinese Population: A Multi-center Retrospective Study
Sep 18, 2025, 18:38 PM -
Comparison of Risk Prediction Models for Kidney Disease: An External Validation Using 0.5 Million UK Biobank Participants
Sep 18, 2025, 18:38 PM -
Economic Evaluations of Orphan Drugs for Rare Kidney Diseases in Low and Middle Income Countries: A Systematic Review and Bibliometric Analysis
Sep 18, 2025, 18:38 PM -
Unlocking the Strategic Potential of Real-World Evidence in the Asia – Pacific Pharmaceutical Market: Executive Insights and Commercial Implications
Sep 18, 2025, 18:38 PM -
A Task-Oriented Multi-Source Heterogeneous Data Fusion Framework for Healthcare and Elderly Care Integration
Sep 18, 2025, 18:38 PM -
Acceptance of Real-World Evidence in HTA in Japan: Is the Potential Being Realized?
Sep 18, 2025, 18:38 PM -
Cost-Effectiveness Analysis of Prenatal Diagnostic Strategies Among Korean Pregnant Women
Sep 18, 2025, 18:38 PM -
Price Variations Among Standardized Voluntary Health Insurance Plans: Evidence From Hong Kong
Sep 18, 2025, 18:38 PM
